Form 4: HilleVax COO Sean McLoughlin Acquires 1,250 Shares of Common Stock

Sentiment:

SEC Form 4 Filing


HilleVax's Chief Operating Officer, Sean McLoughlin, purchased 1,250 shares of the company's common stock at a price of $16.98 per share on March 28, 2024.

Summary

  • On March 28, 2024, Sean McLoughlin, the Chief Operating Officer of HilleVax, Inc. (HLVX), acquired 1,250 shares of common stock.
  • The purchase price was $16.98 per share.
  • Following the transaction, McLoughlin directly owns 1,250 shares of HilleVax common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by an executive. The purchase itself could be seen as mildly positive, indicating confidence, but the document is primarily informational.

Positives

  • The COO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
03/28/2024Date of transaction: Sean McLoughlin purchased 1,250 shares of HilleVax common stock.
04/01/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.